Jasmine J. Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jasmine J. Han has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Hannah A. Song
Department of Bioengineering, University of California, Los Angeles, CA 90024, USA
1 shared publication - Jane Shen-Gunther
Gynecologic Oncology & Molecular Medicine, Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
1 shared publication - Qingqing Xia
Department of Clinical Investigation, Brooke Army Medical Center, San Antonio, TX 78234, USA
1 shared publication - Sarah Pierson
Department of Clinical Investigation, Brooke Army Medical Center, San Antonio, TX 78234, USA
1 shared publication
Latest Publications
- Open Access
- 24 October 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (11) , 2618
Emerging Infectious Diseases Are Virulent Viruses—Are We Prepared? An Overview
The recent pandemic caused by SARS-CoV-2 affected the global population, resulting in a significant loss of lives and global economic deterioration. COVID-19 highlighted the importance of public awareness and science-based decision making, and exposed global vulnerabilities in preparedness and response systems. Emerging and re-emerging viral outbreaks are becoming more frequent due to increased international travel and global warming. These viral outbreaks impose serious public health threats and have transformed national strategies for pandemic preparedness with global economic consequences. At the molecular level, viral mutations and variations are constantly thwarting vaccine efficacy, as well as diagnostic, therapeutic, and prevention strategies. Here, we discuss viral infectious diseases that were epidemic and pandemic, currently available treatments, and surveillance measures, along with their limitations.
- 24 October 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (11) , 2618
Open AccessEmerging Infectious Diseases Are Virulent Viruses—Are We Prepared? An Overview
The recent pandemic caused by SARS-CoV-2 affected the global population, resulting in a significant loss of lives and global economic deterioration. COVID-19 highlighted the importance of public awareness and science-based decision making, and exposed global vulnerabilities in preparedness and response systems. Emerging and re-emerging viral outbreaks are becoming more frequent due to increased international travel and global warming. These viral outbreaks impose serious public health threats and have transformed national strategies for pandemic preparedness with global economic consequences. At the molecular level, viral mutations and variations are constantly thwarting vaccine efficacy, as well as diagnostic, therapeutic, and prevention strategies. Here, we discuss viral infectious diseases that were epidemic and pandemic, currently available treatments, and surveillance measures, along with their limitations.